Long-acting insulin analog detemir displays reduced effects on adipocyte differentiation of human subcutaneous and visceral adipose stem cells

被引:13
|
作者
Cignarelli, A. [1 ]
Perrini, S. [1 ]
Nigro, P. [1 ]
Ficarella, R. [1 ]
Barbaro, M. [1 ]
Peschechera, A. [1 ]
Porro, S. [1 ]
Natalicchio, A. [1 ]
Laviola, L. [1 ]
Puglisi, F. [1 ,2 ]
Giorgino, F. [1 ]
机构
[1] Univ Bari Aldo Moro, Sect Internal Med Endocrinol Androl & Metab Dis, Dept Emergency & Organ Transplantat, Piazza Giulio Cesare 11, I-70124 Bari, Italy
[2] Osped Sarcone, Azienda Sanit Locale Bari, Terlizzi, Italy
关键词
Insulin detemir; Insulin analog; Adipose stem cell; Adipogenesis; Subcutaneous fat; Visceral fat; ONCE-DAILY INITIATION; NPH INSULIN; ADD-ON; ADIPOGENESIS; GLARGINE; ALBUMIN; GLUCOSE; PEOPLE; NN304;
D O I
10.1016/j.numecd.2015.11.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Since treatment with insulin detemir results in a lower weight gain compared to human insulin, we investigated whether detemir is associated with lower ability to promote adipogenesis and/or lipogenesis in human adipose stem cells (ASC). Methods and results: Human ASC isolated from both the subcutaneous and visceral adipose tissues were differentiated for 30 days in the presence of human insulin or insulin detemir. Nile Red and Oil-Red-O staining were used to quantify the rate of ASC conversion to adipocytes and lipid accumulation, respectively. mRNA expression levels of early genes, including Fos and Cebpb, as well as of lipogenic and adipogenic genes, were measured at various phases of differentiation by qRT-PCR. Activation of insulin signaling was assessed by immunoblotting. ASC isolated from subcutaneous and visceral adipose tissue were less differentiated when exposed to insulin detemir compared to human insulin, showing lower rates of adipocyte conversion, reduced triglyceride accumulation, and impaired expression of late-phase adipocyte marker genes, such as Pparg2, Slc2a4, Adipoq, and Cidec. However, no differences in activation of insulin receptor, Akt and Erk and induction of the early genes Fos and Cebpb were observed between insulin detemir and human insulin. Conclusion: Insulin detemir displays reduced induction of the Pparg2 adipocyte master gene and diminished effects on adipocyte differentiation and lipogenesis in human subcutaneous and visceral ASC, in spite of normal activation of proximal insulin signaling reactions. These characteristics of insulin detemir may be of potential relevance to its weight-sparing effects observed in the clinical setting. (C) 2015 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:333 / 344
页数:12
相关论文
共 24 条
  • [1] The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin
    Havelund, S
    Plum, A
    Ribel, U
    Jonassen, I
    Volund, A
    Markussen, J
    Kurtzhals, P
    PHARMACEUTICAL RESEARCH, 2004, 21 (08) : 1498 - 1504
  • [2] The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin
    Svend Havelund
    Anne Plum
    Ulla Ribel
    Ib Jonassen
    Aage Vølund
    Jan Markussen
    Peter Kurtzhals
    Pharmaceutical Research, 2004, 21 : 1498 - 1504
  • [3] An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog
    Raslova, Katarina
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 399 - 410
  • [4] Treatment of Type 1 and Type 2 Diabetes Mellitus with Insulin Detemir, a Long-Acting Insulin Analog
    Young, Jason R.
    McAdam-Marx, Carrie
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2010, 3 : 65 - 80
  • [5] Short-Term Effects of the Long-Acting Insulin Analog Detemir and Human Insulin on Plasma Levels of Insulin-Like Growth Factor-I and Its Binding Proteins in Humans
    Porcellati, Francesca
    Rossetti, Paolo
    Candeloro, Paola
    Lucidi, Paola
    Cioli, Patrizia
    Andreoli, Anna Marinelli
    Ghigo, Ezio
    Bolli, Geremia B.
    Fanelli, Carmine G.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (08) : 3017 - 3024
  • [6] Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin
    Wada, Tsutomu
    Azegami, Mari
    Sugiyama, Maine
    Tsuneki, Hiroshi
    Sasaoka, Toshiyasu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (03) : 269 - 277
  • [7] Gene expression profiles of human subcutaneous and visceral adipose-derived stem cells
    Kim, Boyun
    Lee, Boram
    Kim, Mi-Kyung
    Gong, Seung Pyo
    Park, Noh Hyun
    Chung, Hyun Hoon
    Kim, Hee Seung
    No, Jae Hong
    Park, Woong Yang
    Park, Ae Kyung
    Lim, Jeong Mook
    Song, Yong Sang
    CELL BIOCHEMISTRY AND FUNCTION, 2016, 34 (08) : 563 - 571
  • [8] Euglena extract suppresses adipocyte-differentiation in human adipose-derived stem cells
    Sugimoto, Ryota
    Ishibashi-Ohgo, Naoko
    Atsuji, Kohei
    Miwa, Yuko
    Iwata, Osamu
    Nakashima, Ayaka
    Suzuki, Kengo
    PLOS ONE, 2018, 13 (02):
  • [9] Expression analysis of human adipose-derived stem cells during in vitro differentiation to an adipocyte lineage
    Satish, Latha
    Krill-Burger, J. Michael
    Gallo, Phillip H.
    Etages, Shelley Des
    Liu, Fang
    Philips, Brian J.
    Ravuri, Sudheer
    Marra, Kacey G.
    LaFramboise, William A.
    Kathju, Sandeep
    Rubin, J. Peter
    BMC MEDICAL GENOMICS, 2015, 8
  • [10] Expression analysis of human adipose-derived stem cells during in vitro differentiation to an adipocyte lineage
    Latha Satish
    J. Michael Krill-Burger
    Phillip H. Gallo
    Shelley Des Etages
    Fang Liu
    Brian J. Philips
    Sudheer Ravuri
    Kacey G. Marra
    William A. LaFramboise
    Sandeep Kathju
    J. Peter Rubin
    BMC Medical Genomics, 8